Regulation of complement activity by immunoglobulin: I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes

Journal of Immunology

Volumn 156, Issue 2, 1996, Pages 749-757

  Miletic, Vojislav D ^a   Hester, C Garren ^a   Frank, Michael M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SENSITIZATION; SHEEP ERYTHROCYTE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; BIOLOGICAL TRANSPORT; CATTLE; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT C8; DEPRESSION, CHEMICAL; ERYTHROCYTES; GUINEA PIGS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; RABBITS; SERUM ALBUMIN, BOVINE; SHEEP;

EID: 0030070368     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Imbach, P., S. Barandun, V. d'Apuzo, C. Baumgartner, A. Hirt, A. Morell, E. Rossi, M Schone, M. Vest, and H. P Wagner. 1981. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228
2. Ronda, N., V Hurez, and M D Kazatchkine. 1993. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases. Vox Sang. 64:65.
3. Rosen, F. S. 1993. Putative mechanisms of the effect of intravenous γ-globulin. Clin. Immunol. Immunopathol. 67:S41.
4. Jordan, S. C., and M. Toyoda. 1994. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin. Clin. Exp. Immunol. 97:S31
5. Frank, M. M., M. Basta, and L F Fries. 1992. The effects of intravenous immune globulin on complement-dependent immune damage of cells and tissues. Clin. Immunol. Immunopathol. 62:S82
6. Basta, M., P. F. Langlois, M. Marques, M. M Frank, and L. F. Fries. 1989. High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood 74:326.
7. Basta, M., P. Kirshborn, M M. Frank, and L. F. Fries 1989 Mechanism of therapeutic effect of high-dose intravenous immunoglobulin: attenuation of acute, complement-dependent immune damage in a guinea pig model. J Clin. Invest 84:1974
8. Basta, M., L. F. Fries, and M. M Frank. 1991. High doses of intravenous Ig inhibit in vitro uptake of C4 fragments onto sensitized erythrocytes Blood 77: 376.
9. Basta, M., L. F. Fries, and M. M. Frank. 1991. High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway. Blood 78 700.
10. Steinbuch, M., R. Audran, and L Pejandler. 1973. Preparation of an IgM and IgA enriched fraction for clinical use. Prep. Biochem. 34:363.
11. Garbet, N. D., C. S. Munro, and P. J. Cole. 1989. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with Sandoglobulin. Clin Exp. Immunol. 76:8
12. Klingemann, H G., M. J. Barnett, and G. L Phillips. 1990. Use of an immunoglobulin preparation enriched for IgA to treat recurrent sinopulmonary infections in a patient with chronic GVHD (letter). Bone Marrow Transplant. 5.205.
13. Poynton, C. H., S Jackson, C. Fegan, R. A. Barnes, and J. A. Whittaker. 1992 Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplant. 9:451.
14. Gaither, T. A., and M. M. Frank. 1979. Complement. In Clinical Diagnosis and Management by Laboratory Methods. J. B Henry, ed Saunders, Philadelphia p 1253.
15. Grabar, P., and C. A. Williams. 1953. Methode permettant l'etude conjugeee des proprietes electrophoretiques et immunochimiques d'un melange de proteins, application au serum sanguin Biochim Biophys. Acta 10.193.
16. Laemmli, E. K. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
17. Issitt, P D. 1985. Serological diagnosis and characterization of the causative autoantibodies In Immune Hemolytic Anemias. H. Chaplin, ed. Churchill Livingstone, New York, p. 1.
18. Tatum, A. H 1993. Large scale recovery of biologically active IgM (90% pure) from human plasma obtained by therapeutic plasmapheresis. J. Immunol. Methods 158-1
19. Johnstone, A., and R. Thorpe. 1987. Immunochemistry in practice. Blackwell, Oxford, p 73.
20. Loonies, L. M , W. W Stewart, R. L. Mazengera, B. W. Senior, and M. A Kerr. 1991. Purification and characterization of human immunoglobulin A1 and IgA2 isotypes from serum. J Immunol Methods 141.209.
21. Miletic, I. D., S. S. Schiffmann, E. A. Sattely-Miller, and V D. Miletic 1995. Development of ELISA-based assays for detection, quantitation and avidity determination of salivary IgA anti-gliadin antibodies. Jugoslav. Med. Biochem 14: 15
22. Perosa, F., R Carbone, S Ferrone, and F Dammacco. 1990. Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate. J. Immunol. Methods 128:9.
23. Hammer, C H , G. H. Wirtz, L. Renfer, H. D. Gresham, and B. F. J. Tack. 1981. A large scale isolation of functionally active components of the human complement system J. Biol. Chem. 265:3995.
24. Baatrup, G 1989. Immune complex modulation by plasma proteins. Dan. Med Bull. 36.443
25. Ternynck, T , and S Avrameas. 1972. Polyacrylamide-protein immunoadsorbants prepared with glutaraldehyde. FEBS Letters 23:24.
26. Cohen, S., and E. L. Becker. 1968 The effect of benzylation or sequential amidination and benzylation on the ability of rabbit gG-antibody to fix complement. J Immunol. 100:403.
27. Magee, J. C , B. H Collins, R. C. Harland, B. J. Lindman, R. R Bollinger, M. M. Frank, and J. L. Platt. 1995. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin. Invest. 96: 2404.
28. Basta, M., and M. C. Dalakas. 1994. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J. Clin. Invest 94:1729.
29. Fries, L. F., T. A Gaither, C. H Hammer, and M. M. Frank. 1984. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J. Exp. Med. 160:1640.
30. Miletic, V. D , and M. M. Frank. 1995. Complement-immunoglobulin interactions Curr. Opin Immunol. 7:41.
31. Griffiss, J. M , and G. A. Jarvis. 1987 Interaction of serum IgA with complement components: the molecular basis of IgA blockade. Adv. Exp Med. Biol. 216B:1303.
32. Moller, N. P. H. 1979. Fc-mediated immune precipitation. I. A new role of the Fc-portion of IgG. Immunology 38:631.
33. Fauci, A., M. M Frank, and J S. Johnson 1970. The relationship between antibody affinity and the efficiency of complement fixation. J. Immunol. 105:225.
34. Nomura, S., Y. Myazaki, T. Miyake, K. Yamaguchi, H. Kido, T. Kawakatsu, T. Fukuroi, H. Kagwa, M. Suzuki, M. Yanabu, and T. Kokawa. 1993. IgG inhibits the increase of platelet-associated C3 stimulated by anti-platelet antibodies Clin. Exp. Immunol. 93:452
35. Inagaki, M , and K. Yamada. 1991. Inhibitory effects of high doses of intravenous γ-globulin on platelet interaction with the vessel wall in Kawasaki disease. Acta Paediatr Jpn 33:791.
36. Qi, M., and J. A. Schifferli. 1995. Inhibition of complement activation by intravenous immunoglobulins Arthritis Rheum. 38:146.
37. Mollnes, T. E., K Hogasen, B. F. Hoaas, T. E. Michaelsen, P. Garred, and M Harboe. 1995. Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the Ig isotype and its C1 binding properties. Scand. J. Immunol. 41:449.